Table 3 Return on investment of preventively vaccinating healthcare workers against pertussis
From: Modelling the return on investment of preventively vaccinating healthcare workers against pertussis
Costs in Euros | % | |
|---|---|---|
Direct control costs | ||
Antibiotic therapy (a) | €785 | 2% |
Laboratory investigations (b) | €6,982 | 14% |
Outbreak control management (c) | €3,697 | 8% |
Total (a,b,c) | €11,464 | 24% |
Other outbreak related costs | ||
Absenteeism costs (d) | €21,008 | 43% |
Restrictions on patient uptake on the ward (e) | €47,036 | 33% 2 |
Savings due to reduced staff costs (f)1 | −/− €30,826 | |
Total (d,e,f) | €37,218 | 76% |
Total nosocomial pertussis outbreak costs (g) | €48,682 | 100% |
Vaccination costs (h) | €12,208 | |
Ratio | ||
Return on investment ((g-h)/h) | 1:4 |